Enterprise Financial Services Corp Sage Therapeutics, Inc. Transaction History

Enterprise Financial Services Corp

  • $165 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$40.26 - $57.37 $563 - $803
-14 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$58.41 - $89.06 $817 - $1,246
14 New
14 $1,000
Q4 2018

Jan 25, 2019
SELL
$81.94 - $139.71 $1,311 - $2,235
-16 Closed
0 $0
Q3 2018

Oct 26, 2018
BUY
$138.11 - $169.04 $2,209 - $2,704
16 New
16 $2,000

Others Institutions Holding SAGE

# of Institutions
220
Shares Held
52.7M
Call Options Held
207K
Put Options Held
191K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $730M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email